Vemurafenib Oral Tablet [Zelboraf]
ChiECRCT20210210
Phase 1 small_molecule active
Quick answer
Vemurafenib Oral Tablet [Zelboraf] for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active